Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +12

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leon Caly, Julian Druce, Mike Catton et al. · Antiviral Research · 2020 · 2.3K citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

Cynthia Guzzo, Christine Furtek, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2002 · 366 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019

Juliana Cepelowicz Rajter, Michael S. Sherman, Naaz Fatteh et al. · CHEST Journal · 2020 · 278 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +15

Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle

A. Lifschitz, G. Virkel, J. Sallovitz et al. · Veterinary Parasitology · 2000 · 195 citations

Veterinary Medicine, Infectious Diseases, Veterinary Parasitology +12